મંગળવાર, 8 ઑગસ્ટ, 2017

IIT Delhi team develops a new antibacterial drug-delivery system


7th August:

The nanoconjugates will be useful for cancer patients suffering from bacterial infections. A new antibiotic drug-delivery system that improves the efficacy of drugs thereby reducing the dosage used for treating bacterial infections has been tested in a lab by researchers at the Indian Institute of Technology (IIT) Delhi.

Drug delivery becomes better and the bioavailability improves when the drug is conjugated [bound] to gold nanoparticles. So reduced dosage is sufficient to kill the bacteria. Reducing the dosage of antibiotics used is one of the strategies to reduce the possibility of drug resistance setting in.





ટિપ્પણીઓ નથી:

ટિપ્પણી પોસ્ટ કરો